PURE BIOSCIENCE INC COM STK NEW (DE)
PURE
PURE was delisted on the 16th of May, 2013.
1 hedge funds and large institutions have $187K invested in PURE BIOSCIENCE INC COM STK NEW (DE) in 2017 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 1 → 1 (0)
54% less capital invested
Capital invested by funds: $405K → $187K (-$218K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCM
Goldman Capital Management
New York
|
-$262K |
PURE Hedge Fund Activity: Q2 2017 in Review
1 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in PURE BIOSCIENCE INC COM STK NEW (DE) (PURE) for Q2 2017, worth a combined $187K — down 54% from $405K a quarter earlier.
Fund positioning in PURE was balanced in Q2 2017: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.
The largest seller was Goldman Capital Management, cutting an estimated $262K.
- 1 institutional investor held PURE BIOSCIENCE INC COM STK NEW (DE) (PURE) as of Q2 2017, unchanged from Q1 2017.
- Funds reported $187K of PURE BIOSCIENCE INC COM STK NEW (DE) stock for Q2 2017, down 54% quarter-over-quarter.
- 0 funds opened new PURE BIOSCIENCE INC COM STK NEW (DE) positions in Q2 2017 and 0 closed out.
- The largest PURE BIOSCIENCE INC COM STK NEW (DE) seller in Q2 2017 was Goldman Capital Management, an estimated $262K sold.
Based on aggregated 13F filings for Q2 2017.